Benefits
Topical bruising/ecchymosis reduction (modest evidence)
Seeley 2006 RCT (PMID 16415448, n=29 face-lift patients) showed homeopathic Arnica reduced AREA of ecchymosis on postoperative days 1, 5, 7, 10 — though no subjective patient/staff difference noted, and no objective color difference. The evidence here is modest — even this 'positive' finding shows only one of multiple endpoints favoring arnica. Topical gel evidence (vs homeopathic oral) generally more positive in smaller trials.
Post-surgical pain and edema (mixed evidence)
Iannitti 2016 review (PMID 25171757, Am J Ther) of arnica in post-surgical setting concluded reasonable evidence for non-homeopathic topical formulations reducing pain, edema, and ecchymosis. Totonchi 2007 RCT compared arnica to steroids in postrhinoplasty ecchymosis/edema — non-inferior performance. However, Stevinson 2003 (PMID 12562974, hand surgery RCT) showed homeopathic arnica was NOT effective for pain or bruising. Effect appears formulation-dependent.
Topical osteoarthritis pain relief (vs ibuprofen)
Widrig 2007 RCT (n=204) showed topical arnica gel non-inferior to topical ibuprofen 5% gel for hand osteoarthritis pain over 21 days — both produced significant improvement in pain and hand function. Reasonable evidence for arnica gel as alternative for those who can't use NSAIDs. Lower-quality evidence than for prescription topical NSAIDs (e.g., diclofenac gel).
Delayed-onset muscle soreness (negative for homeopathic)
Vickers 1998 (PMID 9760029) RCT of homeopathic Arnica 30X in long-distance runners — INEFFECTIVE for muscle soreness vs placebo. Combined with other negative homeopathic trials: homeopathic dilutions show NO consistent effect on DOMS. Mechanistic prediction (no active molecules at 30X dilution) confirmed by clinical results.
Mechanism of action
Sesquiterpene lactone NF-κB inhibition (topical, non-homeopathic)
Helenalin (the major sesquiterpene lactone) covalently modifies cysteine residues in p65/NF-κB, blocking transcription of pro-inflammatory genes (TNF-α, IL-1β, IL-6, COX-2). Strong anti-inflammatory effect at concentrations achievable in topical applications. This mechanism explains the bruising/edema benefit observed with non-homeopathic topical preparations.
Capillary support and microcirculation
Topical arnica preparations may strengthen capillary integrity and improve local microcirculation — facilitating clearance of extravasated blood (bruise resolution) and reducing edema. Mechanism involves flavonoid-mediated vascular effects similar to those of bioflavonoids in venous insufficiency.
Mild antimicrobial and platelet effects
Arnica extracts have modest antimicrobial activity against Staphylococcus species and inhibit platelet aggregation in vitro. The platelet effect may contribute to the paradoxical observations of both bruising help (reduced platelet activation prolonging clearance) AND theoretical bleeding risk.
HOMEOPATHIC DILUTION: No detectable active mechanism
At homeopathic dilutions of 30C (1:10⁶⁰) or higher, the probability of even a single original arnica molecule remaining in a typical dose is essentially zero. Any clinical effect of homeopathic arnica must operate via mechanisms NOT involving the labeled compound (placebo effect, ritual/expectation, alcohol vehicle in liquid forms, lactose vehicle in pellets). Essential context for evaluating the arnica evidence base.
Clinical trials
Randomized, double-blind, placebo-controlled trial (Stevinson C, Devaraj VS, Fountain-Barber A, Hawkins S, Ernst E 2003, J R Soc Med 96(2):60-65, doi:10.1177/014107680309600203, PMID 12562974).
Patients undergoing carpal tunnel and similar elective hand surgery randomized to homeopathic Arnica or placebo for prevention of post-surgical pain and bruising.
NEGATIVE TRIAL. No significant difference between homeopathic Arnica and placebo for post-surgical pain or bruising. Combined with similar negative DOMS trial (Vickers 1998), Stevinson concluded that homeopathic Arnica does not have meaningful effect on these outcomes. The pivotal modern trial supporting the conclusion that homeopathic dilutions of Arnica do not perform better than placebo. Frequently cited critically by evidence-based medicine reviewers.
Randomized double-blind placebo-controlled trial (Seeley BM, Denton AB, Ahn MS, Maas CS 2006, Arch Facial Plast Surg 8(1):54-59, doi:10.1001/archfaci.8.1.54, PMID 16415448).
29 patients undergoing rhytidectomy (face-lift) at tertiary care center, treated perioperatively with homeopathic Arnica montana or placebo. Postoperative photographs analyzed using novel computer model for color changes; subjective assessments obtained.
Mixed result: NO subjective differences (patients or professional staff). NO objective color difference. BUT smaller AREA of ecchymosis on postoperative days 1, 5, 7, and 10 in arnica group. The 'positive' finding is on a single endpoint with multiple comparisons — a weak signal that may reflect chance. Often cited as positive arnica evidence, but the totality of findings is much more equivocal than headlines suggest.
Comprehensive review (Iannitti T, Morales-Medina JC, Bellavite P, Rottigni V, Palmieri B 2016, Am J Ther 23(1):e184-e197, doi:10.1097/MJT.0000000000000036, PMID 25171757).
Review of arnica clinical trials in post-surgical setting, pain, and inflammation across formulations (topical gel, cream, oral homeopathic, oral non-homeopathic).
Concluded arnica is reasonably safe and effective for pain, bruising, and inflammation in post-surgical settings — particularly TOPICAL non-homeopathic formulations. Authors flagged formulation-dependent variability and noted that homeopathic dilutions show inconsistent results. Overall recommended arnica as adjunct in post-surgical care, with clearer evidence for topical applications. The most cited modern review supporting clinical use; but reader should note authors are sympathetic to complementary medicine.